Improving health for Black COVID-19 survivors and their caregivers

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study tests a dyadic intervention aimed at improving health outcomes for African American adults who have survived COVID-19 and their informal caregivers. It focuses on individuals with pre-existing chronic health conditions, such as diabetes and cardiovascular diseases, particularly in socioeconomically disadvantaged and rural areas. The intervention, known as iCINGS FAM, is a telehealth program delivered by a team of registered nurses and community health workers over 14 weeks, addressing both health management and social determinants of health. The goal is to enhance chronic disease self-management and overall quality of life for participants.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Male and female
* Living in a Medically Underserved Area and/or a designated rural area of South Carolina
* ≥ 18 years and above
* A previous diagnosis of one or more of the following conditions: type 2 diabetes, hypertension, cardiovascular disease, chronic kidney disease, or stroke (\>3 months)

  -Carepartner inclusion criteria
* Male and female
* ≥ 18 years and above
* Must live on the same property or community, preferably within a 40-mile radius of the patient (dyad member)
* Primarily responsible for care provision and/or care/social support in the home (i.e., is not paid for services)

Exclusion Criteria:

• Enrolled in related clinical trials

.No member of dyad has at least one of the included chronic health conditions

Where it's running

• University of South Carolina
  Columbia, South Carolina, United States Recruiting

Study contacts

• Principal investigator: Gayenell S Magwood, PhD — University of South Carolina
• Study coordinator: Study PI
• Email: magwoodg@sc.edu
• Phone: 8037779160

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Rural Telemedicine-Enabled Care to Prevent Stroke in Older Adults in China

  A telemedicine-supported care model led by rural doctors will be tested to see if it can reduce stroke and heart problems in adults 65+ living in rural China.

  Recruiting at 2 sites Jiangsu Province (Suqian) Hospital · Suqian, Jiangsu and 1 other locations · NCT07628283

• AI-based prediction of five major diseases using integrated health data

  Researchers are testing an AI model to see if they can predict the onset of five major diseases in adults 30–65 by combining medical records with biospecimens and lifestyle data.

  Recruiting Asan Medical Center · Seoul, Seoul Special City · NCT07595718

• Early risk screening for diabetes and heart disease in Ascoli Piceno

  This project tests a new screening program for 50-year-olds in Ascoli Piceno to see if they are at risk for type 2 diabetes and cardiovascular disease.

  Recruiting at 2 sites Marche Region Regional Health Agency · Ascoli Piceno, Ascoli Piceno and 1 other locations · NCT07344701

• Hybrid mirror-primed rehabilitation for unilateral stroke

  This trial will test whether adding enhanced mirror priming to conventional therapy helps adults who had a first-time one-sided stroke at least three months ago improve upper-arm movement.

  Recruiting I-Shou University · Kaohsiung City, Yanchao District · NCT07324278

• Streamlined renal denervation with Spyral for uncontrolled high blood pressure

  This trial will test whether a shorter, simpler renal denervation procedure using the Symplicity Spyral system can lower blood pressure in adults with uncontrolled hypertension.

  Recruiting at 20 sites Medtronic Vascular · Melbourne and 20 other locations · NCT07115953

• Vicadrostat with empagliflozin for people with type 2 diabetes, high blood pressure, and heart disease

  This trial will test whether adding vicadrostat to empagliflozin lowers cardiovascular risk in adults who have type 2 diabetes, high blood pressure, and existing cardiovascular disease but no history of heart failure.

  Recruiting at 1096 sites Phase 3 Boehringer Ingelheim · Anniston, Alabama and 1141 other locations · NCT07064473

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.